p19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor)

774 EUR

100ug

GEN604036

N/A

IgG1

3H2796

p19INK4d

Antibodies

Monoclonal

Mnoclonal antibodies

Human (Homo sapiens)

Mouse (Mus musculus)

CDKN2D; CDKN2D; p19; INK4D; p19-INK4D; N/A

CDKN2D; CDKN2D; p19; INK4D; p19-INK4D; N/A

CDKN2D; CDKN2D; p19; INK4D; p19-INK4D; N/A

Supplied as a liquid in PBS, 0.08% sodium azide.

Affinity Purified by Protein A and Protein G affinity chromatography.

Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC)

Human (Homo sapiens); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Recognizes human p19ink4d. Co-precipitates cdk4/cdk6 in immunoprecipitation studies.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

p19INK4d; Cyclin-dependent kinase 4 inhibitor D; cyclin-dependent kinase 4 inhibitor D; CDK inhibitor p19INK4d; inhibitor of cyclin-dependent kinase 4d; cyclin-dependent kinase 4 inhibitor D p19; cell cycle inhibitor, Nur77 associating protein; cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4); p19-INK4d

Store the antibody at +4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.Kinase, breast cancer tumor, HRAS like - suppressor protein make genetic suppression restoring the phenotype seen prior to the original background in biological pathways.